pyrazines has been researched along with glycine in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (8.16) | 18.7374 |
| 1990's | 3 (6.12) | 18.2507 |
| 2000's | 13 (26.53) | 29.6817 |
| 2010's | 22 (44.90) | 24.3611 |
| 2020's | 7 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bowman, Z; Cooper, CM; Stanton, HC | 1 |
| von Bruchhausen, F | 1 |
| Devik, OG; Kadar, R | 1 |
| Dorman, DE; Engel, GL; Indelicato, JM | 1 |
| Cugola, A; Donati, D; Micheli, F; Missio, A; Pecunioso, A; Reggiani, A; Tarzia, G | 1 |
| Hiramoto, K; Ishihara, T; Kato, T; Kikugawa, K; Maeda, Y; Takada, C; Tanaka, M | 1 |
| Boireau, A; Chevé, M; Damour, D; Genevois-Borella, A; Imperato, A; Jimonet, P; Mignani, S; Pratt, J; Randle, JC; Ribeill, Y; Stutzmann, JM | 1 |
| Hiramoto, K; Kato, T; Kikugawa, K; Yanagawa, H | 1 |
| Brady, CS; FitzGerald, MX; Mackarel, AJ; O'Connor, CM; Russell, KJ | 1 |
| Boireau, A; Bordier, F; Imperato, A; Meunier, M; Monterrat, C | 1 |
| Avendaño, C; Corzo-Suárez, R; Espada, M; Gago, F; García-Granda, S; Martín-Santamaría, S; Rzepa, HS | 1 |
| Adams, A; De Kimpe, N; Kersiene, M; Tehrani, KA; Venskutonis, R | 1 |
| Burkoth, TS; Charych, DH; Connolly, MD; Fafarman, AT; Zuckermann, RN | 1 |
| Kashman, Y; Lang, S; Pappo, D; Vartanian, M | 1 |
| Haffenden, LJ; Yaylayan, VA | 1 |
| Heinzl, S | 1 |
| Amano, S; Ehama, R; Matsunaga, Y; Nishiyama, T; Ogura, Y; Tagami, H | 1 |
| Noda, Y; Peterson, DG | 1 |
| Low, MY; Mottram, DS; Parker, JK | 1 |
| Haldoupis, Y; Koutsidis, G; Mojica-Lazaro, J; Mottram, DS; Simons, SP; Thong, YH; Wedzicha, BL | 1 |
| Bannerman, B; Berger, A; Blank, J; Bolen, J; Bruzzese, F; Cao, Y; Dick, L; Fitzgerald, M; Fleming, P; Garcia, K; Hales, P; Kupperman, E; Lee, EC; Liu, J; Manfredi, M; Rolfe, M; Tsu, C; Yang, Y; Yu, J; Yu, L | 1 |
| Dickschat, JS; Kunze, B; Nawrath, T; Schulz, S | 1 |
| Guerra, PV; Yaylayan, VA | 2 |
| Belmonte, C; Morenilla-Palao, C; Valero, M; Viana, F | 1 |
| Anderson, KC; Chauhan, D; Kuhn, D; Orlowski, R; Raje, N; Richardson, P; Tian, Z; Zhou, B | 1 |
| Bannerman, B; Bano, K; Berger, AJ; Bolen, JB; Bradley, DP; Carsillo, M; Donelan, J; Fitzgerald, M; Hales, P; Janz, S; Kupperman, E; Lee, EC; Li, P; Li, Z; Liu, R; Manfredi, M; Neppalli, VT; Pickard, M; Silva, MD; Subakan, O; Tayber, O; Terkelsen, J; Van Ness, B | 1 |
| Appel, A | 1 |
| Abe, M; Fujii, S | 1 |
| Hu, Y; Wu, P; Zhang, J | 1 |
| Cavallo, F; Genadieva-Stavric, S; Palumbo, A | 1 |
| Itoh, K; Liu, T; Maruyama, A; Mimura, J; Ohyama, C; Okada, T; Sato, H; Ye, P | 1 |
| Yagi, H | 1 |
| D'Arrigo, P; Molla, G; Motta, P; Nardini, M; Panzeri, W; Pollegioni, L | 1 |
| Mitsiades, CS | 1 |
| Anderson, DR; Buisson, B; Fagiolini, M; Fanger, CM; Gleyzes, M; Gordon, E; Menniti, FS; Mierau, SB; Paschetto, K; Sirivolu, VR; Steidl, E; Virginio, C; Volkmann, RA | 1 |
| Arihara, K; Ohata, M; Zhou, L | 1 |
| Dorsett, KN; Hansen, KB; Menniti, FS; Mou, TC; Sprang, SR; Volkmann, RA; Yi, F | 1 |
| Heffley, W; Hughes, MA; Hull, C; Joshua, M; McKinney, A; Song, EY; Taylor, BN; Xu, Z | 1 |
| Tiong, IS; Wei, AH | 1 |
| Eskazan, AE; Kucukyurt, S | 1 |
| Cao, Y; Tong, J; Xu, Y; Zhang, L | 1 |
| DiNardo, CD; Wei, AH | 1 |
| Arihara, K; Ohata, M; Yada, Y; Yokoyama, I; Zhou, L | 1 |
| Dutta, R; Jeng, MY; Mannis, GN; Tan, IT; Zhang, TY | 1 |
| Berg, G; Cernava, T; Erschen, S; Grube, M; Kusstatscher, P; Reisenhofer-Graber, T; Wicaksono, WA | 1 |
| Thol, F | 1 |
| Cui, H; Hayat, K; Ho, CT; Ma, M; Wang, Z; Zhang, X | 1 |
| Hayat, K; Ho, CT; Liu, M; Xu, H; Yu, J; Zhang, X; Zhou, T | 1 |
6 review(s) available for pyrazines and glycine
| Article | Year |
|---|---|
[Dipeptidylpeptidase IV inhibitors and dual action PPAR-agonists].
Topics: Adamantane; Adenosine Deaminase Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Glycine; Glycoproteins; Humans; Hypoglycemic Agents; Nitriles; Oxazoles; Peroxisome Proliferator-Activated Receptors; Protease Inhibitors; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2006 |
Clinical and marketed proteasome inhibitors for cancer treatment.
Topics: Boron Compounds; Boronic Acids; Bortezomib; Glycine; Humans; Lactones; Neoplasms; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Pyrroles; Structure-Activity Relationship; Threonine | 2013 |
New approaches to management of multiple myeloma.
Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Depsipeptides; Frail Elderly; Glycine; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Oligopeptides; Phosphorylcholine; Proteasome Inhibitors; Pyrazines; Quality of Life; Recurrence; Thalidomide; Treatment Outcome | 2014 |
[Proteasome inhibitor].
Topics: Boron Compounds; Boronic Acids; Bortezomib; Glycine; Humans; Molecular Targeted Therapy; Neoplasms; Proteasome Inhibitors; Pyrazines; Ubiquitin | 2014 |
New drugs creating new challenges in acute myeloid leukemia.
Topics: Aminopyridines; Aniline Compounds; Cytarabine; Daunorubicin; fms-Like Tyrosine Kinase 3; Gemtuzumab; Glycine; Humans; Leukemia, Myeloid, Acute; Pyrazines; Pyridines; Staurosporine; Triazines; United States; United States Food and Drug Administration | 2019 |
New drugs approved for acute myeloid leukaemia in 2018.
Topics: Aniline Compounds; Antineoplastic Agents; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Disease-Free Survival; Glycine; Humans; Leukemia, Myeloid, Acute; Phenylurea Compounds; Progression-Free Survival; Pyrazines; Pyridines; Remission Induction; Sulfonamides | 2019 |
1 trial(s) available for pyrazines and glycine
| Article | Year |
|---|---|
Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapies.
Topics: Aged, 80 and over; Aniline Compounds; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclopentanes; Disease-Free Survival; Female; Glycine; Humans; Leukemia, Myeloid, Acute; Male; Pyrazines; Pyridines; Pyrimidines; Retrospective Studies; Sulfonamides; Survival Rate | 2020 |
42 other study(ies) available for pyrazines and glycine
| Article | Year |
|---|---|
Effects of monoamine oxidase inhibitors on isoproterenol-induced cardiomegaly in rats.
Topics: Animals; Carbon Isotopes; Cardiomegaly; DNA; Female; Glycine; Isocarboxazid; Isoniazid; Isoproterenol; Monoamine Oxidase Inhibitors; Myocardium; Nialamide; Nucleic Acids; Pargyline; Phenelzine; Piperidines; Pyrazines; Rats; RNA; Tranylcypromine | 1970 |
[Biosynthesis of the basement membrane. Utilization of proline and glucose for the formation of components of the glomerular basement membrane in vitro].
Topics: Animals; Basement Membrane; Carbon Isotopes; Cattle; Chromatography, Gel; Chromatography, Thin Layer; Cycloheximide; Depression, Chemical; Diuretics; Glucose; Glycine; Glycoproteins; Hydroxyproline; In Vitro Techniques; Kidney Glomerulus; Leucine; Microbial Collagenase; Peptide Hydrolases; Phlorhizin; Proline; Puromycin; Pyrazines; Rats | 1971 |
Pyrazines as interfering substances in the determination of nitrosamines in roasted foods.
Topics: Chromatography, Gas; Food Analysis; Food Handling; Glucose; Glycine; Hot Temperature; Nitrosamines; Polarography; Pyrazines; Spectrum Analysis | 1970 |
2-Hydroxy-3-aryl-6-methylpyrazines-fluorophores formed from the reaction of formaldehyde with cyclic enamine degradation products common to beta-lactam antibiotics with aryl glycine side chains.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; Chemical Phenomena; Chemistry; Formaldehyde; Glycine; Hydrolysis; Pyrazines; Spectrometry, Fluorescence | 1981 |
2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as selective glycine antagonist with in vivo activity.
Topics: Animals; Avoidance Learning; Binding Sites; Cyclic N-Oxides; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glycine; Kynurenic Acid; Mice; Motor Activity; N-Methylaspartate; Neuroprotective Agents; Pyrazines; Rats; Receptors, N-Methyl-D-Aspartate; Seizures; Stereotyped Behavior; Strychnine | 1997 |
Participation of the pyrazine cation radical in the formation of mutagens in the reaction of glucose/glycine/creatinine.
Topics: Cations; Creatinine; Electron Spin Resonance Spectroscopy; Food Analysis; Free Radicals; Glucose; Glycine; Hot Temperature; Maillard Reaction; Mutagenicity Tests; Mutagens; Pyrazines; Salmonella typhimurium | 1999 |
Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo.
Topics: Animals; Binding Sites; Excitatory Amino Acid Antagonists; Glycine; Mice; Pyrazines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Spiro Compounds; Structure-Activity Relationship | 1999 |
Effect of food reductones on the generation of the pyrazine cation radical and on the formation of the mutagens in the reaction of glucose, glycine and creatinine.
Topics: Animals; Antioxidants; Ascorbic Acid; Cations; Creatinine; Electron Spin Resonance Spectroscopy; Food Analysis; Food Contamination; Free Radicals; Glucose; Glycine; In Vitro Techniques; Maillard Reaction; Microsomes, Liver; Mutagenicity Tests; Mutagens; Pyrazines; Rats; Salmonella typhimurium | 2000 |
Interleukin-8 and leukotriene-B(4), but not formylmethionyl leucylphenylalanine, stimulate CD18-independent migration of neutrophils across human pulmonary endothelial cells in vitro.
Topics: CD11 Antigens; CD18 Antigens; Cell Line; Cell Movement; Chemotactic Factors; Dose-Response Relationship, Drug; Endothelium, Vascular; Glycine; Humans; Hydroxamic Acids; Interleukin-8; L-Selectin; Leukotriene B4; Lung; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Permeability; Phenylalanine; Protease Inhibitors; Pyrazines; Sulfonamides; Thiophenes | 2000 |
Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro.
Topics: Animals; Binding, Competitive; Cerebral Cortex; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glycine; In Vitro Techniques; Male; Membranes; Mice; N-Methylaspartate; Phencyclidine; Pyrazines; Rats; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Tritium | 2000 |
Diastereoselective reactions in glycine templates containing an ent-ardeemin fragment.
Topics: Alkylation; Chemistry, Organic; Crystallography, X-Ray; Glycine; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Pyrazines; Pyrimidinones; Quinazolines; Stereoisomerism | 2002 |
Thermal degradation studies of glucose/glycine melanoidins.
Topics: Furans; Gas Chromatography-Mass Spectrometry; Glucose; Glycine; Hot Temperature; Molecular Weight; Polymers; Pyrazines; Pyrroles; Volatilization | 2002 |
Incorporation of unprotected heterocyclic side chains into peptoid oligomers via solid-phase submonomer synthesis.
Topics: Acylation; Biomimetic Materials; Glycine; Imidazoles; Indoles; Peptides; Pyrazines; Pyridines; Quinolines | 2003 |
Synthesis of cyclic endiamino peptides.
Topics: Alanine; Amino Acids, Diamino; Glycine; Peptides, Cyclic; Pyrazines | 2005 |
Mechanism of formation of redox-active hydroxylated benzenes and pyrazine in 13C-labeled glycine/D-glucose model systems.
Topics: Benzene; Carbon Isotopes; Gas Chromatography-Mass Spectrometry; Glucose; Glycine; Hydroxylation; Maillard Reaction; Pyrazines | 2005 |
Establishment of a mouse skin model of the lichenification in human chronic eczematous dermatitis.
Topics: Animals; Disease Models, Animal; Eczema; Epidermis; Glycine; Glycine Agents; Humans; Hydroxamic Acids; Male; Metalloendopeptidases; Mice; Mice, Hairless; Pyrazines; Skin Aging; Sulfonamides | 2007 |
Structure-reactivity relationships of flavan-3-ols on product generation in aqueous glucose/glycine model systems.
Topics: Catechin; Flavonoids; Glucose; Glycine; Maillard Reaction; Phenols; Pyrazines; Structure-Activity Relationship | 2007 |
Mechanisms of alkylpyrazine formation in a potato model system containing added glycine.
Topics: Acrylamides; Alkylation; Amino Acids; Glycine; Hot Temperature; Isotopes; Pyrazines; Solanum tuberosum | 2007 |
Investigations on the effect of amino acids on acrylamide, pyrazines, and Michael addition products in model systems.
Topics: Acrylamide; Amino Acids; Asparagine; Glucose; Glycine; Hot Temperature; Maillard Reaction; Models, Chemical; Pyrazines | 2009 |
Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer.
Topics: Animals; Boron Compounds; Boronic Acids; Bortezomib; Cysteine Proteinase Inhibitors; Drug Screening Assays, Antitumor; Female; Glycine; HCT116 Cells; HT29 Cells; Humans; Lymphoma; Mice; Mice, SCID; Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Xenograft Model Antitumor Assays | 2010 |
The biosynthesis of branched dialkylpyrazines in myxobacteria.
Topics: Aldehydes; Bacteriological Techniques; Carbohydrate Sequence; Culture Media; Gas Chromatography-Mass Spectrometry; Glycine; Isomerism; Myxococcales; Pyrazines; Valine; Volatilization | 2010 |
Dimerization of azomethine ylides: an alternate route to pyrazine formation in the Maillard reaction.
Topics: Azo Compounds; Dimerization; Glycine; Maillard Reaction; Models, Chemical; Oxidation-Reduction; Pyrazines; Thiosemicarbazones | 2010 |
Pharmacological and functional properties of TRPM8 channels in prostate tumor cells.
Topics: Arginine; Calcium; Cell Line; Cell Line, Tumor; Cell Membrane; Clotrimazole; Cold Temperature; Endoplasmic Reticulum; Glycine; Humans; Male; Menthol; Prostate; Prostatic Neoplasms; Pyrazines; Pyridines; Pyrimidinones; TRPM Cation Channels | 2011 |
In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Blotting, Western; Boron Compounds; Boronic Acids; Bortezomib; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dexamethasone; Drug Synergism; Enzyme Activation; Glycine; Humans; Lenalidomide; Mice; Mice, SCID; Multiple Myeloma; NF-kappa B; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Thalidomide; Xenograft Model Antitumor Assays | 2011 |
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies.
Topics: Animals; Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Cell Line, Tumor; Glycine; Humans; Lymphoma, B-Cell; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Neoplasms, Plasma Cell; Osteolysis; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Xenograft Model Antitumor Assays | 2011 |
Drugs: More shots on target.
Topics: Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Clinical Trials as Topic; Drug Resistance, Neoplasm; Glycine; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Oligopeptides; Protease Inhibitors; Pyrazines; Survival Rate; Thalidomide; Threonine | 2011 |
Double Schiff base adducts of 2,3-butanedione with glycine: formation of pyrazine rings with the participation of amino acid carbon atoms.
Topics: Amino Acids; Diacetyl; Glycine; Maillard Reaction; Molecular Structure; Pyrazines; Schiff Bases | 2012 |
[Molecular targeting agents for multiple myeloma].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Glycine; Histone Deacetylases; Humans; Immunologic Factors; Lactones; Lenalidomide; Molecular Targeted Therapy; Multiple Myeloma; Oligopeptides; Proteasome Inhibitors; Pyrazines; Pyrroles; Thalidomide | 2012 |
Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.
Topics: Activating Transcription Factor 4; Amino Acid Transport System y+; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cysteine; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glutathione; Glycine; HEK293 Cells; HeLa Cells; Humans; Leupeptins; NF-E2-Related Factor 2; Oligopeptides; Proteasome Endopeptidase Complex; Pyrazines; RNA, Small Interfering; Sulfasalazine; Urinary Bladder Neoplasms | 2014 |
Aminoacetone oxidase from Streptococcus oligofermentans belongs to a new three-domain family of bacterial flavoproteins.
Topics: Acetone; Crystallography, X-Ray; Enzyme Activation; Flavoproteins; Glycine; Models, Molecular; Multigene Family; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Protein Structure, Tertiary; Pyrazines; Streptococcus | 2014 |
Therapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathway.
Topics: Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Cell Line, Tumor; Clinical Trials as Topic; Glycine; Hematologic Neoplasms; Humans; Neoplasms; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Signal Transduction; Ubiquitin | 2015 |
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit.
Topics: Animals; CA1 Region, Hippocampal; Calcium; Cells, Cultured; Dogs; Excitatory Postsynaptic Potentials; Female; Glutamic Acid; Glycine; Humans; Ion Channel Gating; Madin Darby Canine Kidney Cells; Male; Neurons; Oocytes; Protein Subunits; Pyrazines; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Sulfonamides; Xenopus | 2016 |
Effects of odor generated from the glycine/glucose Maillard reaction on human mood and brainwaves.
Topics: Adult; Affect; Brain Waves; Evaluation Studies as Topic; Female; Furans; Glucose; Glycine; Humans; Hydrogen-Ion Concentration; Maillard Reaction; Male; Models, Biological; Odorants; Olfactory Perception; Pilot Projects; Pyrazines; Taste; Temperature; Volatile Organic Compounds; Young Adult | 2016 |
Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
Topics: Allosteric Regulation; Allosteric Site; Animals; Crystallography; Glycine; Models, Molecular; Pyrazines; Receptors, N-Methyl-D-Aspartate; Sulfonamides; Xenopus laevis | 2016 |
Coordinated cerebellar climbing fiber activity signals learned sensorimotor predictions.
Topics: Action Potentials; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cerebellum; Excitatory Amino Acid Agents; Glycine; Guanine Nucleotide Exchange Factors; Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Nerve Fibers; Neural Pathways; Neurons; Neuropeptides; Principal Component Analysis; Pyrazines; Reaction Time; Synaptic Transmission | 2018 |
An Alkylpyrazine Synthesis Mechanism Involving l-Threonine-3-Dehydrogenase Describes the Production of 2,5-Dimethylpyrazine and 2,3,5-Trimethylpyrazine by Bacillus subtilis.
Topics: Acetone; Acetyl Coenzyme A; Acetyltransferases; Alcohol Oxidoreductases; Bacillus subtilis; Catalysis; Flavoring Agents; Glycine; Pyrazines; Threonine | 2019 |
How I treat acute myeloid leukemia in the era of new drugs.
Topics: Adult; Aged; Aminopyridines; Aniline Compounds; Antineoplastic Agents; Biomarkers, Tumor; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Daunorubicin; Female; fms-Like Tyrosine Kinase 3; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Molecular Targeted Therapy; Mutation; Prognosis; Pyrazines; Pyridines; Sialic Acid Binding Ig-like Lectin 3; Staurosporine; Sulfonamides; Triazines | 2020 |
2,3-Dimethylpyrazine (3DP) and 2,5-dimethyl-4-hydroxy-3(2
Topics: Anger; Anxiety; Autonomic Nervous System; Central Nervous System; Female; Food; Furans; Glucose; Glycine; Humans; Maillard Reaction; Male; Odorants; Pyrazines; Young Adult | 2020 |
Antimicrobial-specific response from resistance gene carriers studied in a natural, highly diverse microbiome.
Topics: Anti-Infective Agents; Ascomycota; Colistin; Drug Resistance, Microbial; Glycine; Glyphosate; Microbiota; Pyrazines; RNA, Ribosomal, 16S; Tetracycline | 2021 |
What to use to treat AML: the role of emerging therapies.
Topics: Aged; Aminopyridines; Aniline Compounds; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Approval; Drug Discovery; Glycine; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Pyrazines; Pyridines; Triazines | 2021 |
Controlled Formation of Pyrazines: Inhibition by Ellagic Acid Interaction with
Topics: Ellagic Acid; Glycine; Maillard Reaction; Oxidation-Reduction; Pyrazines | 2022 |
Formation Priority of Pyrazines and 2-Acetylthiazole Dependent on the Added Cysteine and Fragments of Deoxyosones during the Thermal Process of the Glycine-Ribose Amadori Compound.
Topics: Cysteamine; Cysteine; Glycine; Glyoxal; Magnesium Oxide; Maillard Reaction; Pyrazines; Pyruvaldehyde; Ribose; Thiazoles | 2022 |